Figure 1From: A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinomaStudy Enrollment and Treatment. CONSORT Diagram.Back to article page